✦ LIBER ✦

Ultrastructure of pulmonary bleomycin toxicity

✍ Scribed by Carlos W. M. Bedrpssian; Mario A. Luna; Bruce Mackay; Benjamin Lichtiger

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 1006 KB
Volume: 32
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197307)32:1<44::aid-cncr2820320106>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleomycin pulmonary toxicity: Its relati

Bleomycin pulmonary toxicity: Its relationship to renal dysfunction

✍ Dalgleish, Angus G. ;Woods, Robert L. ;Levi, John A. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

Two hundred seventy-five patients who had received bleomycin were examined for evidence of pulmonary toxicity. Twenty-six patients were diagnosed as having bleomycin pulmonary toxicity and, of these, 20 (77%) were documented as having renal dysfunction without other features recognized to be associa

The ultrastructure of pulmonary hamartom

The ultrastructure of pulmonary hamartoma

✍ Frederick J. Stone; Andrew M. Churg 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

Ultrastructural and histochemical examination of chondromatous pulmonary hamartomas revealed the epithelial component to be comprised of elements similar to those lining the distal bronchioles and the alveoli of adult lung. The stromal cells nearest the epithelium include a population resembling mat

Modulation of bleomycin-induced pulmonar

Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine

✍ Linda Nici; Anabela Santos-Moore; Charles Kuhn; Paul Calabresi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## BACKGROUND. Bleomycin produces lung fibrosis in a wide variety of species. In humans, it can cause significant morbidity and mortality when used to treat malignancies such as lymphoma and testicular carcinoma. In rodents, it has been extensively used to study key mechanisms of lung injury and r

Enhanced pulmonary toxicity with bleomyc

Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer

✍ Lawrence Einhorn; Maurice Krause; Ned Hornback; Becky Furnas 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

In a recently completed study, combination chemotherapy consisting of bleomycin, adriamycin, cyclophosphamide, a n d vincristine was given to 29 patients with oat cell lung cancer. There were no cases of pulmonary fibrosis in these 29 patients. Although several of these patients had prior radiothera

Long-term pulmonary toxicity of multiage

Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors

✍ Kharasch, Virginia S.; Lipsitz, Stuart; Santis, William; Hallowell, Jennifer A.; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Purpose:To assess long-term pulmonary effects of multiagent chemotherapy, we studied serial pulmonary function tests (PFTs) of 35 children with osteosarcoma up to 12 years after diagnosis. Patients and Methods: We analyzed 84 sets of PFTs from 35 patients diagnosed with osteosarcoma between 1981 an

Gemcitabine added to doxorubicin, bleomy

Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease : Unacceptable acute pulmonary toxicity

✍ Jonathan W. Friedberg; Donna Neuberg; Helen Kim; Sarah Miyata; Mary McCauley; Da 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

## Abstract ## BACKGROUND Gemcitabine is an effective treatment for recurrent Hodgkin disease (HD), with relatively minimal associated toxicity. The authors conducted a trial substituting this drug for dacarbazine in the standard regimen to form ABVG (doxorubicin, bleomycin, vinblastine, gemcitabi